This statistic depicts the percentage of obesity clinical trials for novel drugs that were successful in the period from 2006 to 2015, by phase and indication. According to the data, among obesity NME/biologics just 1.4 percent were successful from phase I to approval.
Clinical trial success rates for novel obesity drugs between 2006 and 2015, by phase and indication
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Biotechnology Innovation Organization. (February 26, 2019). Clinical trial success rates for novel obesity drugs between 2006 and 2015, by phase and indication [Graph]. In Statista. Retrieved November 21, 2024, from https://www.statista.com/statistics/992056/obesity-clinical-trial-success-rates-since-2006-by-phase-and-indication-us/
Biotechnology Innovation Organization. "Clinical trial success rates for novel obesity drugs between 2006 and 2015, by phase and indication." Chart. February 26, 2019. Statista. Accessed November 21, 2024. https://www.statista.com/statistics/992056/obesity-clinical-trial-success-rates-since-2006-by-phase-and-indication-us/
Biotechnology Innovation Organization. (2019). Clinical trial success rates for novel obesity drugs between 2006 and 2015, by phase and indication. Statista. Statista Inc.. Accessed: November 21, 2024. https://www.statista.com/statistics/992056/obesity-clinical-trial-success-rates-since-2006-by-phase-and-indication-us/
Biotechnology Innovation Organization. "Clinical Trial Success Rates for Novel Obesity Drugs between 2006 and 2015, by Phase and Indication." Statista, Statista Inc., 26 Feb 2019, https://www.statista.com/statistics/992056/obesity-clinical-trial-success-rates-since-2006-by-phase-and-indication-us/
Biotechnology Innovation Organization, Clinical trial success rates for novel obesity drugs between 2006 and 2015, by phase and indication Statista, https://www.statista.com/statistics/992056/obesity-clinical-trial-success-rates-since-2006-by-phase-and-indication-us/ (last visited November 21, 2024)
Clinical trial success rates for novel obesity drugs between 2006 and 2015, by phase and indication [Graph], Biotechnology Innovation Organization, February 26, 2019. [Online]. Available: https://www.statista.com/statistics/992056/obesity-clinical-trial-success-rates-since-2006-by-phase-and-indication-us/
